Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Seller turnover on Ozon in 2023 increased 2.5 times

3/28/24 OZON

Inter RAO closed the deal to purchase the Ural Turbine Plant

3/28/24 IRAO

Saratov Oil Refinery reported for 2023 by RAS

3/28/24 KRKN

X5 Group opened the largest Pyatyorochki retail center in the Urals

3/28/24 X5

MMK import substitution of wire and nuts

3/28/24 MAGN

Tinkoff entered in register of DFA issuance operators

3/28/24 T

SFI reported for 2023 by IFRS

3/28/24 SFIN

Kristall reported for January-February 2024

3/28/24 KLVZ

Gokhran unexpectedly started buying stones from Alrosa

3/28/24 ALRS

Supervisory Board was replenished with new members

3/28/24 X5